iShares U.S. Pharmaceuticals ETF (IHE)

iShares U.S. Pharmaceuticals ETF is trading at $102.78, down 0.67% on the session. The 50 day average sits at $102.41 and the 200 day at $93.92, which puts the stock in a uptrend. RSI is at 49.5, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $100.34 with resistance near $103.64, so that band frames the current range. Average daily movement is roughly $1.79, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 72 out of 100 combines a trend score of 77, momentum of 65 and a risk score of 74.

The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.